Key facts
- Bain Capital Life Sciences is a venture capital firm based in Boston, Massachusetts with 17 tracked portfolio companies.
- Notable positions include Freenome, Imperative Care, HeartFlow (NAS: HTFL), Kailera Therapeutics (NAS: KLRA), Areteia Therapeutics.
- Bain Capital Life Sciences has 4 funds on record.
- The team roster lists 30 people.
- Bain Capital Life Sciences reports $66.7B in regulatory assets under management across 36 private funds, per its SEC Form ADV (2026-03).
About Bain Capital Life Sciences
Founded in 2016, Bain Capital Life Sciences is the corporate venture capital arm of Bain Capital, based in Boston, Massachusetts. The firm seeks to invest in companies operating in the pharmaceutical, biotechnology, medical device, diagnostic, and life science sectors.
Registered with the SEC
Form ADV · 2026-03 · CRD 145653- Regulatory AUM
- $66.7B
- Private fund assets
- $99.5B
- Private funds
- 36 · 36 private equity
- Staff
- 919
- Registered office
- BOSTON, MA
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as BAIN CAPITAL PRIVATE EQUITY, LP).
Free account
See the whole book
- ·The book's top 25 — of 17 recorded positions
- ·Watchlist + alerts for Bain Capital Life Sciences's activity
Create free account
No card required
Portfolio, priced
17 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | $2.2B | — | |
| Imperative Care | Surgical Devices | $1.6B | — | |
| HeartFlow (NAS: HTFL) | Decision/Risk Analysis | $1.5B | — | |
| Kailera Therapeutics (NAS: KLRA) | — | $1.5B | — | |
| Areteia Therapeutics | Drug Discovery | $1.3B | — | |
| Cardurion | Biotechnology | $760.0M | — | |
| Abcuro | Drug Discovery | $700.0M | — | |
| Avistone Pharmaceuticals Biotechnology | — | $628.3M | — | |
| Synthekine | — | $500.0M | — | |
| Rivus Pharmaceuticals | Drug Discovery | $489.0M | — | |
| Interius BioTherapeutics | — | $350.0M | — | |
| Timberlyne Therapeutics | — | $324.2M | — | |
| Merida Biosciences | Biotech | $228.0M | — | |
| Apreo Health | — | $183.0M | — | |
| CereVasc | — | $135.0M | — | |
| + 2 more companies · a free account shows the top of the book | ||||
Funds
4 recorded- Bain Capital Life Sciences Fund IV, L.P.2024—
- Bain Capital Life Sciences Fund III, L.P.2021—
- Bain Capital Life Sciences Fund II, L.P.2019—
- Bain Capital Life Sciences Fund, L.P.2016—
Team
30 people on record — 30 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Bain Capital Life Sciences invest in?
- Bain Capital Life Sciences has 17 recorded portfolio companies, including Freenome, Imperative Care, HeartFlow (NAS: HTFL), Kailera Therapeutics (NAS: KLRA).
- What is Bain Capital Life Sciences's AUM?
- Bain Capital Life Sciences manages approximately $4.6B in assets.